Nephrogen raised $0.22 million to engineer AI-driven gene delivery vectors for kidney and pancreatic diseases, enabling researchers and clinicians to advance genomic therapies and improve patient outcomes.
Nephrogen raised $0.22 million to engineer AI-driven gene delivery vectors for kidney and pancreatic diseases, enabling researchers and clinicians to advance genomic therapies and improve patient outcomes.
